Oxytocin
Neurohypophysial Peptide | Social Bonding & Reproductive Hormone
Oxytocin is a nine-amino-acid peptide hormone and neuropeptide naturally produced in the hypothalamus and released by the posterior pituitary. Known as the "love hormone" or "bonding hormone," it plays fundamental roles in social bonding, trust, empathy, sexual reproduction, childbirth, and lactation. Synthetic oxytocin (Pitocin/Syntocinon) is FDA-approved for labor induction and postpartum hemorrhage control, while intranasal formulations are being researched for autism spectrum disorders, anxiety, depression, PTSD, chronic pain, and sexual dysfunction.
Daily dose
20-40 IU (intranasal)
Frequency
1-2 times daily
Cycle length
4-12 weeks
Storage
2-8°C
Key benefits
FDA-approved for labor induction, extensively researched for social bonding, anxiety reduction, PTSD therapy augmentation, autism spectrum disorders, and sexual function enhancement
How it works
Binds to oxytocin receptors (OXTR) in brain regions involved in social cognition (amygdala, hippocampus, prefrontal cortex) and reproductive tissues. Modulates GABAergic, serotonergic, and dopaminergic neurotransmission. Reduces cortisol and HPA axis activity. Also acts as agonist at opioid receptors and TRPV1 pain receptors.
Dosage protocols
Goal
Social anxiety/bonding enhancement
Dose
20-24 IU · Once daily or before social situations
Route
Intranasal spray
Goal
PTSD therapy augmentation
Dose
40 IU · Before therapy sessions
Route
Intranasal spray
Goal
Sexual function enhancement
Dose
24-40 IU · 30-45 minutes before activity
Route
Intranasal spray
Goal
General wellness/mood
Dose
10-20 IU · Once daily
Route
Intranasal spray
Goal
Sublingual option
Dose
50-100 IU · Once daily
Route
Sublingual troche
Research indications
social
mental
reproductive
Administration
Interactions
Safety notes
Generally well-tolerated with minimal systemic effects at research doses
Common side effects: mild headache, nasal irritation, occasional nausea
Monitor electrolytes if exceeding 24 IU daily long-term
May transiently affect blood pressure
Not recommended during pregnancy without medical supervision
Effects on in-group bias noted - be aware of social context
Consult healthcare provider before use, especially with psychiatric conditions
Research studies
Intranasal Oxytocin for Obesity (2024)
Human RCT | N=61 adults with obesity | 24 IU four times daily | 8 weeks | NEJM Evidence
Treatment did not result in weight loss but showed significant reduction in caloric intake at test meals and improvement in mental health-related quality of life. No serious adverse events.
View study →Oxytocin Effects on Social Cognition in Schizophrenia (2023)
Human RCT | N=68 | 24 IU twice daily | 12 weeks | Schizophrenia Research
While no significant advantage over placebo on primary social cognition outcomes, oxytocin showed modest improvement in social functioning and within-group reduction in negative symptoms.
View study →Intranasal Oxytocin in Autism Spectrum Disorder (2021)
Human Phase 2 RCT | N=290 children/adolescents | 48 IU daily | 24 weeks | NEJM
Large randomized controlled trial found intranasal oxytocin did not significantly improve social functioning in children and adolescents with ASD compared to placebo, highlighting need for better patient selection and dosing strategies.
View study →Oxytocin Augmented Prolonged Exposure Therapy for PTSD (2019)
Human RCT | Veterans with PTSD | 40 IU intranasal | Combined with PE therapy
Participants receiving oxytocin demonstrated lower PTSD and depression symptoms during prolonged exposure therapy and reported higher therapeutic alliance scores compared to placebo.
View study →Chronic Intranasal Oxytocin Effects on Male Sexual Function (2012)
Human case study | 40 IU intranasal | Multi-week chronic use
First documented case of broad-spectrum benefits of chronic intranasal oxytocin on male sexual function including improved libido, erection quality, and orgasm intensity.
View study →